May / June 2024

Women in Pharma® Editorial: An Era of Innovation and Emerging Technologies

Vivien E. Santillan
Vivien E. Santillan

The emergence of new modalities and innovations on drug development and research, such as advanced therapy medicinal products (ATMPs) and personalized and precise therapies, presents new opportunities for the treatment and management of diseases and injuries. As these innovations continue to evolve, the regulatory landscape likewise evolves and this has led to the production of higher-quality, safer, and more efficacious medicines.

ATMPs: Challenges and Solutions

Recent studies indicate that investment in ATMPs is expected to spawn growth in terms of the establishment of research facilities and related infrastructure. However, challenges in manufacturing sector flexibility are expected as the industry adapts to the new and emerging technologies. These challenges include standardization, interoperability, integration of legacy systems to new technologies, regulation, and security, among others. It is therefore imperative that these factors be given serious consideration along with the perceived improvements, efficiencies, and benefits.

Among the equally important aspects that can bring about effective technology diffusion and adaptation are capacity development in human resources, improvements in infrastructure and research facilities, education, and knowledge management, which must be supported by relevant and responsive government regulatory policies.

Of these, human resource capacity development is where an organization has direct control and influence. In recent times, it is no longer sufficient to have a workforce with appropriate skill sets. The global landscape requires the organization to empower the same workforce not only with knowledge on technology innovations but with awareness of market and social developments as well. This is where the organization can have meaningful impact.

Adapting to change and enabling the organization for continuous improvement will lay the foundation for an engaged and responsive workforce.

Making a Difference With Ispe Women in Pharma®

ISPE is acknowledged as a forerunner in scientific, technical, and regulatory advancement throughout the entire pharmaceutical life cycle. As a global leader, ISPE offers its members different platforms to obtain technical proficiency. It is also a great resource for training and workshop requirements in the industry. Consistent to the demands of the global market, ISPE members are trusted to provide relevant and responsive solutions and perspectives to the ever-changing landscape of the pharmaceutical industry.

Women in Pharma is a community within ISPE that provides a forum for collaborations on technical and career advancement topics that aims to balance the needs for personal and professional growth. Its programs include mentorship of its members, promoting safe space for meaningful conversations, and fostering partnerships, among others. This community offers a venue to pursue personal development through building relationships to create social impact. It also seeks out opportunities to lead and make a difference to shape the future of pharma. It is cognizant of the important role that the workforce plays in organizations and endeavors to leverage diversity, equity, and inclusion to drive operational excellence within the workplace.

Adapting to change and enabling the organization for continuous improvement will lay the foundation for an engaged and responsive workforce. Or-ganizations must not only have an awareness of this dynamic but should also be mindful of its essential requisites. The benefits of a workforce with the necessary skill sets and a well-rounded perspective of the needs of the market will redound not only to the organization, but to the industry as well. This is where ISPE and Women in Pharma can help. Let us connect, collaborate, and inspire our workforce and the future generations to adapt by continuously seeking knowledge.

Learn More